Department of Neurosurgery, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany.
Department of Neurosurgery, University hospital of Augsburg, Augsburg, Germany.
Neurosurg Rev. 2021 Oct;44(5):2809-2818. doi: 10.1007/s10143-020-01462-5. Epub 2021 Jan 17.
Treatment of patients with failed back surgery syndrome (FBSS) with predominant low back pain (LBP) remains challenging. High-frequency spinal cord stimulation (HF10 SCS) is believed to achieve significant pain reduction. We aimed to evaluate the real-life efficacy of HF-10 SCS in a tertiary spine center. A prospective observational study of all patients with FBSS and predominant LBP who underwent HF-10 SCS surgery was performed between 2016 and 2018. Patients > 18 years with Visual Analogue Scale (VAS) scores of ≥ 5 for LBP and pain duration > 6 months under stable medication were implanted percutaneous under general anesthesia and a trial phase of 7-14 days was accomplished. Primary end point was a successful trial defined as ≥ 50% VAS score reduction for LBP. Thirty-four of 39 (85%) subjects had a successful trial. Fifty-three percent were female and the mean age was 69 years. Median follow-up lasted for 10 months. Devices were removed after a median of 10 months in 5 cases. Remaining 29 patients stated significant VAS score reduction for LBP from 8.1 to 2.9 and VAS for leg pain from 4.9 to 2.2. Twenty-four percent of all patients were able to discontinue their opioids. Eight of 9 patients (89%) with signs of adjacent disc disease and 7 of 10 (70%) patients with hardware failure were successfully implanted with significant VAS reduction for LBP. HF-10 SCS achieves significant pain reduction in most patients with FBSS and predominant LBP. It might be an efficient alternative to revision surgery.
治疗以腰痛为主的失败性腰椎手术综合征(FBSS)患者仍然具有挑战性。高频脊髓刺激(HF10 SCS)被认为可显著减轻疼痛。我们旨在评估三级脊柱中心中 HF-10 SCS 的真实疗效。对 2016 年至 2018 年间接受 HF-10 SCS 手术的所有以腰痛为主的 FBSS 患者进行了前瞻性观察性研究。在稳定药物治疗下腰痛的视觉模拟评分(VAS)≥5 且疼痛持续时间>6 个月的>18 岁患者接受全身麻醉下经皮植入和 7-14 天的试验阶段。主要终点是成功的试验定义为腰痛的 VAS 评分降低≥50%。39 例患者中有 34 例(85%)进行了成功的试验。53%为女性,平均年龄为 69 岁。中位随访时间为 10 个月。5 例患者在中位时间 10 个月后取出了设备。其余 29 名患者表示腰痛的 VAS 评分从 8.1 降至 2.9,腿痛的 VAS 评分从 4.9 降至 2.2。所有患者中有 24%能够停止使用阿片类药物。9 例有相邻椎间盘疾病迹象的患者中有 8 例(89%),10 例有硬件故障的患者中有 7 例(70%)植入成功,腰痛的 VAS 评分显著降低。HF-10 SCS 可使大多数以腰痛为主的 FBSS 患者显著减轻疼痛。它可能是一种有效的翻修手术替代方法。